STE vs TELO · P/E 25, rev $5.46B vs $86.0M cap
STERIS plc (STE) versus Telomir Pharmaceuticals, Inc. Common Stock (TELO) — a side-by-side from cached financials, not a winner call.
STERIS plc (STE) is a medical devices company listed on NYSE.
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is a biotechnology company listed on NASDAQ.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
TELO does not have a complete income-statement cache yet.
STE currently screens at market cap $19.43B and trailing P/E 25.1. TELO currently screens at market cap $86.0M.
Not investment advice. Open the STE and TELO stock pages for the full models.
Not investment advice.